Journal
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
Volume 29, Issue 2, Pages 244-258Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2015.04.019
Keywords
Pain; Fibromyalgia; Inflammatory arthritis; Systemic lupus erythematosus (SLE)
Categories
Funding
- MRC [MC_UP_A620_1018, MC_UU_12011/5] Funding Source: UKRI
- Medical Research Council [U1475000005, MC_UP_A620_1018, MC_UU_12011/5] Funding Source: researchfish
- Arthritis Research UK [20665] Funding Source: Medline
- Medical Research Council [MC_UP_A620_1018, MC_UU_12011/5] Funding Source: Medline
Ask authors/readers for more resources
At the end of 2013, 35 million people worldwide were infected with HIV. The prognosis of HIV has been transformed by combination antiretroviral therapy (cART). Providing compliance is good, the use of cART has normalised the life expectancy of HIV-infected people leading to a growing population of people with chronic infection. Management of HIV patients has therefore needed to adapt in order to not only control viral activity but also manage long-term complications of HIV and cART. Rheumatological manifestations of HIV were first described in 1989. Since then, there have been case reports, case series and epidemiological studies describing different clinical manifestations of HIV in the musculoskeletal system. This review will encompass musculoskeletal pain, fibromyalgia, systemic lupus erythematosus (SLE) and inflammatory arthritis in HIV. We will aim to report on the prevalence of these conditions and the risk factors, explore the impact of the virus on the clinical presentations and discuss implications for diagnosis and management. (c) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available